Battelle/BIO State Bioscience Initiatives 2010
The bioscience sector has continued to create jobs even in the midst of recession, Battelle/BIO finds in its annual State Bioscience Initiatives report.
12/14/2010
"Not every biotech company made it through the storm. Fifty publicly traded companies went bankrupt for lack of access to capital. But there is much good news. Biotech stocks outperformed virtually every other index in the first quarter of this year. The markets have come back but Biotech has come back faster and stronger," said Jim Greenwood, president and CEO of BIO.
While total private sector employment dropped 0.7 percent from 2007-2008, bioscience employment grew by 1.4 percent. Research, testing, and medical laboratories account for more than 176,000 jobs added from 2001-2008, representing nine of 10 new bioscience jobs created during that time.
States are taking advantage of this growth by investing in major bioscience initiatives; focusing on agricultural biotech and bioenergy; and implementing tax programs favorable to bio companies.
Project Announcements
Wyandot Snacks Expands Marion, Ohio, Production Operations
08/29/2025
Trane Technologies Expands Fort Smith, Arkansas, Operations
08/29/2025
BioMADE Plans Boone, Iowa, Bioindustrial Manufacturing Operations
08/29/2025
Choice Fabricators Expands Rainbow City, Alabama, Production Operations
08/29/2025
Ranovus Expands Ottawa, Ontario, Semiconductor Operations
08/29/2025
Belgium-Based Stow Group Plans Gordon County, Georgia, Manufacturing Operations
08/28/2025
Most Read
-
Tariffs, Talent, and U.S. Expansion
Q3 2025
-
What We’re Getting Wrong About Gen Z’s Future in the Skilled Trades
Q3 2025
-
Data Center Demand Stabilizes Amid Changing Market Forces
Q3 2025
-
A New Course for U.S. Shipbuilding
Q3 2025
-
Optimizing Your Rail-Served Transportation Network: Strategy Before Steel
Q2 2025
-
In Focus: AI Is Changing Incentives Math
Q2 2025
-
Rewriting the Rules of Warehouse ROI
Q3 2025